Drawing for IGC

USPTO serial 78409319

IGC

Reviewed by CopyMark Law Group

Status 607
Filing date
Status date
Registration date
—
Examiner
CHHINA, KARANENDRA S
Law office
TMO LAW OFFICE 114 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with IGC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Howard Sobelman

HOWARD SOBELMAN SNELL & WILMER LLPONE ARIZONA CTR 400 E VAN BURENPHOENIX, AZ 85004-2202UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001DNA microarrays, RNA microarrays and protein expressions for scientific and medical researchACTIVEMar 1, 2002
009Computer hardware and software for use in medical and scientific research and analysis; equipment to analyze biological materials, namely, diagnostic devices and specimen collection packages for scientific and research use; computer hardware devices and software to develop microarraysACTIVEMar 1, 2002

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 28, 2007MAB7ABANDONMENT NOTICE MAILED - DEFECTIVE USE STATEMENT—
Mar 27, 2007ABN7ABANDONMENT - DEFECTIVE USE STATEMENT—
Aug 14, 2006CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 14, 2006CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 12, 2006SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jun 19, 2006IUAFUSE AMENDMENT FILED—
Jun 19, 2006EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Dec 20, 2005NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 27, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 7, 2005NPUBNOTICE OF PUBLICATION—
Jul 19, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 15, 2005ALIEASSIGNED TO LIE—
Jul 13, 2005CNEAEXAMINERS AMENDMENT MAILED—
Jul 12, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 12, 2005CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 16, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Jun 3, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 3, 2005MAILPAPER RECEIVED—
Dec 14, 2004CPEAEXAMINER'S AMENDMENT AND/OR PRIORITY ACTION MAILED—
Dec 13, 2004CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Nov 23, 2004DOCKASSIGNED TO EXAMINER—
May 5, 2004NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance